<- Go Home
Indegene Limited
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Market Cap
INR 127.6B
Volume
792.7K
Cash and Equivalents
INR 4.9B
EBITDA
INR 5.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 29.8B
Profit Margin
97.95%
52 Week High
INR 681.70
52 Week Low
INR 499.00
Dividend
0.38%
Price / Book Value
4.45
Price / Earnings
28.74
Price / Tangible Book Value
5.52
Enterprise Value
INR 116.1B
Enterprise Value / EBITDA
20.19
Operating Income
INR 4.9B
Return on Equity
17.06%
Return on Assets
9.27
Cash and Short Term Investments
INR 12.7B
Debt
INR 1.2B
Equity
INR 28.7B
Revenue
INR 30.4B
Unlevered FCF
-INR 2.3B
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium